María Jimena Prieto

Author

María Jimena Prieto

Also Known As

Jimena Prieto, M Jimena Prieto, M. J. Prieto, M. Jimena Prieto, M.J Prieto, M.J. Prieto, Maria J. Prieto, Maria Jimena Prieto, María J. Blanco Prieto, María J. Blanco Prieto

Publications

Citations

H-Index

Concepts

All Affiliations

National University of Quilmes Consejo Nacional de Investigaciones Científicas y Técnicas Instituto Multidisciplinario de Biología Celular Universidad de Buenos Aires Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas

About

María Jimena Prieto is an author at National University of Quilmes specializing in medicine, pharmacology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	704
2	Engineering	6	6	173
3	Biochemistry	5	5	136
4	Natural Sciences	4	4	73
5	Social Sciences	1	1	21

María Jimena Prieto

Publications

956

Citations

H-Index

Page 1

	Year	Citations
PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization Daniela E. Igartúa, Carolina Martínez, C. Facundo Temprana, International Journal of Pharmaceutics NanomedicineNeurodegenerative DiseasesMedicinePamam DendrimersNeuropharmacology	2018	114
Combined Therapy for Alzheimer’s Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity Daniela E. Igartúa, Carolina Martínez, S. Alonso, AAPS PharmSciTech Neurodegenerative DiseasesAlzheimer's DiseaseMedicineSide EffectsNeuropharmacology	2020	91
Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent María Jimena Prieto, D. Bacigalupe, Oscar R. Pardini, International Journal of Pharmaceutics NanomedicinePotential Antitoxoplasmic AgentMedicineNano-drug DeliveryChemistry	2006	57
Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough María José Morilla, Jorge Montanari, María Jimena Prieto, International Journal of Pharmaceutics African TrypanosomiasisAntiparasitic AgentParasitic ProtozoaIntravenous Liposomal BenznidazolePharmacology	2004	53
In vivo study of teratogenic and anticonvulsant effects of antiepileptics drugs in zebrafish embryo and larvae Carolina Martínez, Daniela Agustina Feas, Macarena Siri, Neurotoxicology and Teratology Developmental BiologyMedicineAntiepileptics DrugsNeuroscienceCentral Nervous System	2018	48
BSA-capped gold nanoclusters as potential theragnostic for skin diseases: Photoactivation, skin penetration, in vitro, and in vivo toxicity Cristian Lillo, María Natalia Calienni, María Belén Rivas Aiello, Materials Science and Engineering C NanoparticlesNanomedicineEngineeringPotential TheragnosticNanocluster	2020	42
Optimization and In Vivo Toxicity Evaluation of G4.5 Pamam Dendrimer-Risperidone Complexes María Jimena Prieto, Nahuel Eduardo del Río Zabala, Cristian Hernán Marotta, PLoS ONE Pharmaceutical SciencePharmacotherapyExperimental PharmacologyPharmaceutical ChemistryNanomedicine	2014	41
Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer–risperidone complexes María Jimena Prieto, C. Facundo Temprana, Nahuel Eduardo del Río Zabala, European Journal of Medicinal Chemistry NanomedicineBiochemistryMedicineDrug Delivery SystemsPharmacotherapy	2010	37
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, Advanced Drug Delivery Reviews EngineeringCardiovascular Disease TherapeuticsGene DeliveryBiomedical EngineeringTherapeutics	2024	37
Nanotoxicological and teratogenic effects: A linkage between dendrimer surface charge and zebrafish developmental stages María Natalia Calienni, Daniela Agustina Feas, Daniela E. Igartúa, Toxicology and Applied Pharmacology Comparative ToxicologyBiochemistryZebrafish Developmental StagesDevelopmental ToxicologyTeratogenic Effects	2017	36

Page 1